345 related articles for article (PubMed ID: 32387451)
1. Pre-mRNA splicing defects and RNA binding protein involvement in Niemann Pick type C disease.
Paron F; Dardis A; Buratti E
J Biotechnol; 2020 Jul; 318():20-30. PubMed ID: 32387451
[TBL] [Abstract][Full Text] [Related]
2. Finding pathogenic commonalities between Niemann-Pick type C and other lysosomal storage disorders: Opportunities for shared therapeutic interventions.
Yañez MJ; Marín T; Balboa E; Klein AD; Alvarez AR; Zanlungo S
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165875. PubMed ID: 32522631
[TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics study with mutation shows that N-terminal domain structural re-orientation in Niemann-Pick type C1 is required for proper alignment of cholesterol transport.
Yoon HJ; Jeong H; Lee HH; Jang S
J Neurochem; 2021 Mar; 156(6):967-978. PubMed ID: 32880929
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial GSH replenishment as a potential therapeutic approach for Niemann Pick type C disease.
Torres S; Matías N; Baulies A; Nuñez S; Alarcon-Vila C; Martinez L; Nuño N; Fernandez A; Caballeria J; Levade T; Gonzalez-Franquesa A; Garcia-Rovés P; Balboa E; Zanlungo S; Fabrías G; Casas J; Enrich C; Garcia-Ruiz C; Fernández-Checa JC
Redox Biol; 2017 Apr; 11():60-72. PubMed ID: 27888692
[TBL] [Abstract][Full Text] [Related]
5. Targeting defective sphingosine kinase 1 in Niemann-Pick type C disease with an activator mitigates cholesterol accumulation.
Newton J; Palladino END; Weigel C; Maceyka M; Gräler MH; Senkal CE; Enriz RD; Marvanova P; Jampilek J; Lima S; Milstien S; Spiegel S
J Biol Chem; 2020 Jul; 295(27):9121-9133. PubMed ID: 32385114
[TBL] [Abstract][Full Text] [Related]
6. Niemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrin.
Vance JE; Karten B
J Lipid Res; 2014 Aug; 55(8):1609-21. PubMed ID: 24664998
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Molecular Features of Early Infantile Niemann Pick Type C Disease.
Seker Yilmaz B; Baruteau J; Rahim AA; Gissen P
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709131
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary abnormalities in animal models due to Niemann-Pick type C1 (NPC1) or C2 (NPC2) disease.
Roszell BR; Tao JQ; Yu KJ; Gao L; Huang S; Ning Y; Feinstein SI; Vite CH; Bates SR
PLoS One; 2013; 8(7):e67084. PubMed ID: 23843985
[TBL] [Abstract][Full Text] [Related]
9. Overview of clinical, molecular, and therapeutic features of Niemann-Pick disease (types A, B, and C): Focus on therapeutic approaches.
Hosseini K; Fallahi J; Razban V; Sirat RZ; Varasteh M; Tarhriz V
Cell Biochem Funct; 2024 Jun; 42(4):e4028. PubMed ID: 38715125
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of primidone in Niemann-Pick disease type C (NPC)-model cells and mice: Reduction of unesterified cholesterol levels in cells and extension of lifespan in mice.
Ashikawa H; Mogi H; Honda T; Nakamura H; Murayama T
Eur J Pharmacol; 2021 Apr; 896():173907. PubMed ID: 33503462
[TBL] [Abstract][Full Text] [Related]
11. Altered vitamin E status in Niemann-Pick type C disease.
Ulatowski L; Parker R; Davidson C; Yanjanin N; Kelley TJ; Corey D; Atkinson J; Porter F; Arai H; Walkley SU; Manor D
J Lipid Res; 2011 Jul; 52(7):1400-10. PubMed ID: 21550990
[TBL] [Abstract][Full Text] [Related]
12. FTY720/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and sphingolipid accumulation in Niemann-Pick type C mutant fibroblasts.
Newton J; Hait NC; Maceyka M; Colaco A; Maczis M; Wassif CA; Cougnoux A; Porter FD; Milstien S; Platt N; Platt FM; Spiegel S
FASEB J; 2017 Apr; 31(4):1719-1730. PubMed ID: 28082351
[TBL] [Abstract][Full Text] [Related]
13. Laboratory diagnosis of the Niemann-Pick type C disease: an inherited neurodegenerative disorder of cholesterol metabolism.
Sitarska D; Ługowska A
Metab Brain Dis; 2019 Oct; 34(5):1253-1260. PubMed ID: 31197681
[TBL] [Abstract][Full Text] [Related]
14. Endo-lysosomal dysfunction and neuronal-glial crosstalk in Niemann-Pick type C disease.
Malara M; Prestel M; Tahirovic S
Philos Trans R Soc Lond B Biol Sci; 2024 Apr; 379(1899):20220388. PubMed ID: 38368932
[TBL] [Abstract][Full Text] [Related]
15. Reduction of TMEM97 increases NPC1 protein levels and restores cholesterol trafficking in Niemann-pick type C1 disease cells.
Ebrahimi-Fakhari D; Wahlster L; Bartz F; Werenbeck-Ueding J; Praggastis M; Zhang J; Joggerst-Thomalla B; Theiss S; Grimm D; Ory DS; Runz H
Hum Mol Genet; 2016 Aug; 25(16):3588-3599. PubMed ID: 27378690
[TBL] [Abstract][Full Text] [Related]
16. 2-Hydroxypropyl-gamma-cyclodextrin overcomes NPC1 deficiency by enhancing lysosome-ER association and autophagy.
Singhal A; Krystofiak ES; Jerome WG; Song B
Sci Rep; 2020 May; 10(1):8663. PubMed ID: 32457374
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors correct the cholesterol storage defect in most Niemann-Pick C1 mutant cells.
Pipalia NH; Subramanian K; Mao S; Ralph H; Hutt DM; Scott SM; Balch WE; Maxfield FR
J Lipid Res; 2017 Apr; 58(4):695-708. PubMed ID: 28193631
[TBL] [Abstract][Full Text] [Related]
18. Endosomal/lysosomal processing of gangliosides affects neuronal cholesterol sequestration in Niemann-Pick disease type C.
Zhou S; Davidson C; McGlynn R; Stephney G; Dobrenis K; Vanier MT; Walkley SU
Am J Pathol; 2011 Aug; 179(2):890-902. PubMed ID: 21708114
[TBL] [Abstract][Full Text] [Related]
19. Impaired Retromer Function in Niemann-Pick Type C Disease Is Dependent on Intracellular Cholesterol Accumulation.
Dominko K; Rastija A; Sobocanec S; Vidatic L; Meglaj S; Lovincic Babic A; Hutter-Paier B; Colombo AV; Lichtenthaler SF; Tahirovic S; Hecimovic S
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948052
[TBL] [Abstract][Full Text] [Related]
20. Niemann-Pick Disease Type C: from molecule to clinic.
Tang Y; Li H; Liu JP
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):132-40. PubMed ID: 19566836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
